Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Peroxisomal biogenesis disorders (PBD) are autosomal recessive diseases caused by mutations in specific PEX genes that impair peroxisome formation, leading to multi-systemic failure. Symptoms vary, even in patients with variants in the same PEX gene. Our goal is to select PEX mutations and use Drosophila to model a severity spectrum based on genotype-phenotype correlations. Utilizing KozakGAL4 (KZ) cassettes, we replaced the coding sequence of Pex with a GAL4 driver, ideal for making 'humanized' flies in which human PEX can replace the fly loss. We generated Pex2KZ and Pex16KZ lines and assessed them in various behavior assays, confirming their severe phenotypes. We performed rescue with human reference, variant PEX2 and PEX16 alleles, and phenotypic rescue was observed when human PEX2Ref or PEX16Ref were expressed in Pex2KZ or Pex16KZ flies, respectively. We identified a severity spectrum for PEX2 and PEX16 alleles, with some missense mutations exhibiting severity comparable to truncations. Alleles linked to mild PBD showed partial rescue, while variants associated with atypical ataxia could fully rescue. Drosophila humanization is an effective method to study the range of severity of PBD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352285PMC
http://dx.doi.org/10.1242/dmm.052258DOI Listing

Publication Analysis

Top Keywords

pex2 pex16
12
biogenesis disorders
8
severity spectrum
8
pex2kz pex16kz
8
pex16 alleles
8
severity
5
pex
5
distinguishing pex2
4
pex16 gene
4
gene variant
4

Similar Publications

Peroxisomal biogenesis disorders (PBD) are autosomal recessive diseases caused by mutations in specific PEX genes that impair peroxisome formation, leading to multi-systemic failure. Symptoms vary, even in patients with variants in the same PEX gene. Our goal is to select PEX mutations and use Drosophila to model a severity spectrum based on genotype-phenotype correlations.

View Article and Find Full Text PDF

Peroxisomal Biogenesis Disorders Zellweger Spectrum (PBD-ZSD) disorders are a group of autosomal recessive defects in peroxisome formation that produce a multi-systemic disease presenting at birth or in childhood. Well documented clinical biomarkers such as elevated very long chain fatty acids (VLCFA) are key biochemical diagnostic findings in these conditions. Additional, secondary biochemical alterations such as elevated very long chain lysophosphatidylcholines are allowing newborn screening for peroxisomal disease.

View Article and Find Full Text PDF

Peroxisomal biogenesis disorders (PBD) are autosomal recessive disorders caused by loss-of-function mutations of one of the genes responsible for peroxisomal formation. Impaired peroxisome assembly causes severe multisystemic failure with patient phenotypes ranging from epilepsy, liver disease, feeding issues, biochemical abnormalities, and neurodegeneration. Variants in the same gene can produce wide differences in severity, ranging from individuals with death in the first year of life to adults with milder complications.

View Article and Find Full Text PDF
Article Synopsis
  • X-linked adrenoleukodystrophy (X-ALD) is a genetic neurodegenerative disorder marked by a mutation in a gene that causes the buildup of very long-chain fatty acids (VLCFAs) and leads to a range of symptoms, from early childhood neuroinflammatory disorders in some males to chronic issues in adult males and female carriers.
  • Nearly all male patients show signs of adrenal gland failure, with the age of onset varying and sometimes being the first sign of the disease.
  • Studies in fruit flies reveal that knocking down the fly version of the affected gene leads to VLCFA accumulation and other defects, while overexpressing the human version of the gene may inhibit the creation of peroxisomes, suggesting a
View Article and Find Full Text PDF

Peroxisomal Biogenesis Disorders Zellweger Spectrum (PBD-ZSD) disorders are a group of autosomal recessive defects in peroxisome formation that produce a multi-systemic disease presenting at birth or in childhood. Well documented clinical biomarkers such as elevated very long chain fatty acids (VLCFA) are key biochemical diagnostic findings in these conditions. Additional, secondary biochemical alterations such as elevated very long chain lysophosphatidylcholines are allowing newborn screening for peroxisomal disease.

View Article and Find Full Text PDF